Continuous Improvement and the Expansion of Quality ... - NCQA

T H E S TAT E o f H E A l T H C A R E Q U A l I T y 2 0 1 1 • A P P E N D I C E S
HEdIs EffECtIvEnEss of CarE MEasurEs
PublICly rEPortIng vs. nonPublICly rEPortIng Plans:
MEdICaId HMo avEragEs—2010
MEASURE PUblIC NoNPUblIC DIffERENCE
Disease Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis 70.6 68.7 1.9
Use of Appropriate Medications for People With Asthma—5–11 years 91.8 91.8 0.0
Use of Appropriate Medications for People With Asthma—12–50 years 85.8 85.9 -0.2
Use of Appropriate Medications for People With Asthma—overall Rate 88.5 88.1 0.4
Use of Spirometry Testing in the Assessment and Diagnosis of CoPD 30.4 34.2 -3.8
Pharmacotherapy Management of CoPD—bronchodilators 82.5 81.1 1.4
Pharmacotherapy Management of CoPD—Systemic Corticosteroids 65.4 65.2 0.2
Annual Monitoring for Patients on Persistent Medications—ACE Inhibitors or ARbs 86.3 85.5 0.8
Annual Monitoring for Patients on Persistent Medications—Anticonvulsants 68.4 66.1 2.4
Annual Monitoring for Patients on Persistent Medications—Digoxin 89.3 91.1 -1.8
Annual Monitoring for Patients on Persistent Medications—Diuretics 85.9 84.6 1.2
Annual Monitoring for Patients on Persistent Medications—Combined 84.0 83.6 0.4
Antidepressant Medication Management—Acute Phase 50.0 52.0 -1.9
Antidepressant Medication Management—Continuation Phase 33.5 36.0 -2.5
follow-Up After Hospitalization for Mental Illness—Within 7 Days Post-Discharge 45.9 42.0 3.9
follow-Up After Hospitalization for Mental Illness—Within 30 Days Post-Discharge 65.2 61.1 4.1
Alcohol and other Drug Dependence Treatment—Engagement 14.8 13.3 1.4
Alcohol and other Drug Dependence Treatment—Initiation 44.5 40.5 4.1
Measures targeted toward Children and adolescents
Appropriate Testing for Children With Pharyngitis 64.3 66.1 -1.8
Appropriate Testing for Children With Upper Respiratory Infection 86.9 87.8 -0.9
Childhood Immunization Status—DTaP/DT 80.4 79.7 0.7
Childhood Immunization Status—Hepatitis b 90.9 88.1 2.8
Childhood Immunization Status—Hib 90.7 89.1 1.7
Childhood Immunization Status—IPV 91.3 89.7 1.6
Childhood Immunization Status—MMR 91.2 89.4 1.8
Childhood Immunization Status—Pneumococcal Conjugate (PCV) 80.0 77.7 2.3
Childhood Immunization Status—VzV 90.6 88.8 1.7
Childhood Immunization Status—Combination 2
(DTaP, IPV, MMR, Hib, Hepatitis b and VzV)
Childhood Immunization Status—Combination 3
(DTaP, IPV, MMR, Hib, Hepatitis b, VzV and PCV)
74.8 72.5 2.3
70.7 67.9 2.8
Childhood Immunization Status—Hepatitis A 37.4 34.1 3.3
Childhood Immunization Status—Rotavirus 58.7 55.0 3.7
Childhood Immunization Status—Influenza 43.9 42.6 1.3
159